1. Home
  2. OXBR vs NXL Comparison

OXBR vs NXL Comparison

Compare OXBR & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oxbridge Re Holdings Limited

OXBR

Oxbridge Re Holdings Limited

N/A

Current Price

$0.89

Market Cap

7.1M

Sector

Finance

ML Signal

N/A

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$0.37

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OXBR
NXL
Founded
2013
2010
Country
Cayman Islands
United States
Employees
3
7
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
8.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OXBR
NXL
Price
$0.89
$0.37
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
9.8K
121.2K
Earning Date
05-11-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$497.99
$120.99
Revenue Next Year
$42.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$0.36
52 Week High
$2.85
$2.31

Technical Indicators

Market Signals
Indicator
OXBR
NXL
Relative Strength Index (RSI) 42.26 33.69
Support Level $0.76 N/A
Resistance Level $0.95 $0.62
Average True Range (ATR) 0.06 0.03
MACD 0.01 0.00
Stochastic Oscillator 54.02 3.59

Price Performance

Historical Comparison
OXBR
NXL

About OXBR Oxbridge Re Holdings Limited

Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: